Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 408

1.

Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE risk categories.

De Bacquer D, Dallongeville J, Kotseva K, Cooney MT, Pajak A, Deckers JW, Mayer O, Vanuzzo D, Lehto S, Fras Z, Östor E, Ambrosio GB, De Backer G, Wood D, Keil U, Sans S, Graham I, Pyörälä K.

Int J Cardiol. 2013 Sep 30;168(2):910-4. doi: 10.1016/j.ijcard.2012.10.051. Epub 2012 Nov 14.

PMID:
23157810
2.

Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range.

Ning F, Zhang L, Dekker JM, Onat A, Stehouwer CD, Yudkin JS, Laatikainen T, Tuomilehto J, Pyörälä K, Qiao Q; DECODE Finnish and Swedish Study Investigators.

Cardiovasc Diabetol. 2012 Jun 25;11:76.

3.

Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men.

Bodegard J, Skretteberg PT, Gjesdal K, Pyörälä K, Kjeldsen SE, Liestøl K, Erikssen G, Erikssen J.

J Intern Med. 2012 Jun;271(6):581-8. doi: 10.1111/j.1365-2796.2011.02480.x. Epub 2011 Nov 30.

4.

Relationship between body mass index and mortality among Europeans.

Song X, Pitkäniemi J, Gao W, Heine RJ, Pyörälä K, Söderberg S, Stehouwer CD, Zethelius B, Tuomilehto J, Laatikainen T, Tabák AG, Qiao Q; DECODE Study Group.

Eur J Clin Nutr. 2012 Feb;66(2):156-65. doi: 10.1038/ejcn.2011.145. Epub 2011 Aug 10.

PMID:
21829217
5.

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U; EUROASPIRE Study Group.

Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40. doi: 10.1097/HJR.0b013e3283383f30.

PMID:
20577089
6.

Diabetes, prediabetes and cancer mortality.

Zhou XH, Qiao Q, Zethelius B, Pyörälä K, Söderberg S, Pajak A, Stehouwer CD, Heine RJ, Jousilahti P, Ruotolo G, Nilsson PM, Calori G, Tuomilehto J; DECODE Study Group.

Diabetologia. 2010 Sep;53(9):1867-76. doi: 10.1007/s00125-010-1796-7. Epub 2010 May 21.

PMID:
20490448
7.

Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range.

Ning F, Tuomilehto J, Pyörälä K, Onat A, Söderberg S, Qiao Q; DECODE Study Group.

Diabetes Care. 2010 Oct;33(10):2211-6. doi: 10.2337/dc09-2328. Epub 2010 Apr 27.

8.

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):121-37. doi: 10.1097/HJR.0b013e3283294b1d.

PMID:
19287307
9.

Hyperglycemia and incidence of ischemic and hemorrhagic stroke-comparison between fasting and 2-hour glucose criteria.

Hyvärinen M, Tuomilehto J, Mähönen M, Stehouwer CD, Pyörälä K, Zethelius B, Qiao Q; DECODE Study Group.

Stroke. 2009 May;40(5):1633-7. doi: 10.1161/STROKEAHA.108.539650. Epub 2009 Mar 12.

PMID:
19286584
10.

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group.

Lancet. 2009 Mar 14;373(9667):929-40. doi: 10.1016/S0140-6736(09)60330-5.

PMID:
19286092
11.

Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria.

Hyvärinen M, Qiao Q, Tuomilehto J, Laatikainen T, Heine RJ, Stehouwer CD, Alberti KG, Pyörälä K, Zethelius B, Stegmayr B; DECODE Study Group.

Diabetes Care. 2009 Feb;32(2):348-54. doi: 10.2337/dc08-1411. Epub 2008 Nov 18.

12.

[European practice guidelines on prevention of cardiovascular diseases: executive summary].

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL; Quarta Task Force Congiunta della Società Europea di Cardiologia e; Società sulla Prevenzione delle Malattie Cardiovascolari nella Pratica Clinica (costituita da altre nove società ed esperti invitati).

G Ital Cardiol (Rome). 2008 Jan;9(1):11-59. Italian. No abstract available.

PMID:
18383763
13.

Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries.

Hemingway H, Langenberg C, Damant J, Frost C, Pyörälä K, Barrett-Connor E.

Circulation. 2008 Mar 25;117(12):1526-36. doi: 10.1161/CIRCULATIONAHA.107.720953. Epub 2008 Mar 17. Review.

PMID:
18347213
14.

Coronary events in persons aged 75 years or older in Finland from 1995 to 2002: the FINAMI study.

Koukkunen H, Salomaa V, Lehto S, Ketonen M, Immonen-Räihä P, Lehtonen A, Havulinna A, Kesäniemi YA, Pyörälä K; FINAMI Study Group.

Am J Geriatr Cardiol. 2008 Mar-Apr;17(2):78-86.

PMID:
18326953
15.

Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.

Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

Diabetes Care. 2008 Apr;31(4):714-9. Epub 2007 Dec 14.

PMID:
18083789
16.

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen mL, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); WONCA Europe (European Society of General Practice/Family Medicine); European Heart Network (EHN); European Atherosclerosis Society (EAS).

Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113. No abstract available.

PMID:
17726407
17.

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN).

Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:E1-40. No abstract available.

PMID:
17726406
18.

European guidelines on cardiovascular disease prevention in clinical practice: executive summary.

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL; ESC Committee for Practice Guidelines.

Atherosclerosis. 2007 Sep;194(1):1-45. Epub 2007 Sep 18. No abstract available.

PMID:
17880983
19.

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG).

Eur Heart J. 2007 Oct;28(19):2375-414. Epub 2007 Aug 28. No abstract available.

PMID:
17726041
20.

Long-term prognosis after coronary artery bypass surgery.

Ketonen M, Pajunen P, Koukkunen H, Immonen-Räihä P, Mustonen J, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Arstila M, Vuorenmaa T, Lehtonen A, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Airaksinen J, Pyörälä K, Salomaa V; FINMONICA/FINAMI Study Group.

Int J Cardiol. 2008 Feb 20;124(1):72-9. Epub 2007 Mar 26.

PMID:
17383028
21.

Serum zinc level and coronary heart disease events in patients with type 2 diabetes.

Soinio M, Marniemi J, Laakso M, Pyörälä K, Lehto S, Rönnemaa T.

Diabetes Care. 2007 Mar;30(3):523-8.

PMID:
17327315
22.

Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.

Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

Diabetes Care. 2007 Feb;30(2):292-9.

PMID:
17259497
23.

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyörälä K, Raz I, Schernthaner G, Volpe M, Wood D; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD).

Eur Heart J. 2007 Jan;28(1):88-136. No abstract available.

PMID:
17220161
24.

Cardiovascular risk prediction systems have to be adapted and updated to current national conditions.

Pyörälä K.

Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):674-5. No abstract available.

PMID:
17001204
25.

Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart.

Bartnik M, Rydén L, Malmberg K, Ohrvik J, Pyörälä K, Standl E, Ferrari R, Simoons M, Soler-Soler J; Euro Heart Survey Investigators.

Heart. 2007 Jan;93(1):72-7. Epub 2006 Aug 11.

26.

The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993-2002: the FINAMI study.

Salomaa V, Ketonen M, Koukkunen H, Immonen-Räihä P, Lehtonen A, Torppa J, Kuulasmaa K, Kesäniemi YA, Pyörälä K; FINAMI Study Group.

Eur Heart J. 2006 Oct;27(20):2394-9. Epub 2006 Jul 3.

PMID:
16818460
27.

Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.

Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

Diabetologia. 2006 Jan;49(1):56-65. Epub 2005 Dec 20.

PMID:
16365726
28.

Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

Diabetes Care. 2005 Dec;28(12):2901-7.

PMID:
16306552
29.

Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study.

Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Kärjä-Koskenkari P, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V.

Diabetologia. 2005 Dec;48(12):2519-24. Epub 2005 Oct 25.

PMID:
16247597
30.

Smoking behaviour in European patients with established coronary heart disease.

Scholte op Reimer W, de Swart E, De Bacquer D, Pyörälä K, Keil U, Heidrich J, Deckers JW, Kotseva K, Wood D, Boersma E.

Eur Heart J. 2006 Jan;27(1):35-41. Epub 2005 Oct 6.

PMID:
16210309
31.

Five-year risk of developing clinical diabetes after first myocardial infarction; the FINAMI study.

Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Kärjä-Koskenkari P, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Juolevi A, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V.

Diabet Med. 2005 Oct;22(10):1334-7.

PMID:
16176192
32.

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).

De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, Pyorälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsene T, Wood D; European Association for the Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Atherosclerosis Society (EAS); European Heart Network (EHN); European Society of Caridiology (ESC); European Society of Hypertension (ESH); International Society of Behavioural Medicine (ISBM); European Society of General Practice/Family Medicine (ESGP/FM).

Arch Mal Coeur Vaiss. 2004 Oct;97(10):1019-30. No abstract available.

PMID:
16008181
33.

A new definition for myocardial infarction: what difference does it make?

Salomaa V, Koukkunen H, Ketonen M, Immonen-Räihä P, Kärjä-Koskenkari P, Mustonen J, Lehto S, Torppa J, Lehtonen A, Tuomilehto J, Kesäniemi YA, Pyörälä K.

Eur Heart J. 2005 Sep;26(17):1719-25. Epub 2005 Apr 6.

PMID:
15814567
34.

The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease.

Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Kärjä-Koskenkari P, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V.

Eur J Cardiovasc Prev Rehabil. 2005 Apr;12(2):132-7.

PMID:
15785298
35.

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study.

Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyörälä K; DECODE Study Group; European Diabetes Epidemiology Group.

Diabetologia. 2004 Dec;47(12):2118-28. Epub 2004 Dec 15.

PMID:
15662552
36.

[Spanish adaptation of the European guidelines on cardiovascular prevention (and II)].

de Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergemane O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, Pyörälä K, Rodicio J, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; Tercer Grupo de Trabajo de las Sociedades Europeas y otras Sociedades Sobre la Prevención Cardiovascular en la Práctica Clínica.

Aten Primaria. 2004 Nov 30;34(9):484-92. Spanish. No abstract available.

PMID:
15563787
37.

Gender difference in the impact of type 2 diabetes on coronary heart disease risk.

Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

Diabetes Care. 2004 Dec;27(12):2898-904.

PMID:
15562204
38.

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.

Pedersen TR, Olsson AG, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyörälä K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ; Scandinavian Simavastatin Survival Study Group.

Atheroscler Suppl. 2004 Oct;5(3):99-106. No abstract available.

PMID:
15531282
39.

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, Pyörälä K, Miettinen T, Wilhelmsen L, Olsson AG, Wedel H; Scandinavian Simvastatin Survival Study Group.

Atheroscler Suppl. 2004 Oct;5(3):81-7. No abstract available.

PMID:
15531279
40.

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

Bartnik M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, Standl E, Soler-Soler J, Ohrvik J; Euro Heart Survey Investigators.

Eur Heart J. 2004 Nov;25(21):1880-90.

PMID:
15522466
41.

[European Guidelines on Cardiovascular Disease Prevention in the Clinical Practice. Third work group of the european societies and other societies on cardiovascular disease prevention in the clinical practice].

de Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D.

Neurologia. 2004 Oct;19(8):440-50. Spanish. No abstract available.

PMID:
15470585
42.

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

Strandberg TE, Pyörälä K, Cook TJ, Wilhelmsen L, Faergeman O, Thorgeirsson G, Pedersen TR, Kjekshus J; 4S Group.

Lancet. 2004 Aug 28-Sep 3;364(9436):771-7.

PMID:
15337403
43.

Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys.

Pyörälä K, Lehto S, De Bacquer D, De Sutter J, Sans S, Keil U, Wood D, De Backer G; EUROASPIRE I and II Groups*.

Diabetologia. 2004 Jul;47(7):1257-1265. doi: 10.1007/s00125-004-1438-z. Epub 2004 Jul 2.

PMID:
15235774
44.

Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).

Pyörälä K, Ballantyne CM, Gumbiner B, Lee MW, Shah A, Davies MJ, Mitchel YB, Pedersen TR, Kjekshus J; Scandinavian Simvastatin Survival Study (4S).

Diabetes Care. 2004 Jul;27(7):1735-40.

PMID:
15220255
45.

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts).

De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; European Society of Cardiology. American Heart Association. American College of Cardiology.

Atherosclerosis. 2004 Apr;173(2):381-91. No abstract available.

PMID:
15195638
46.

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.

Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group.

Arch Intern Med. 2004 May 24;164(10):1066-76.

PMID:
15159263
47.
48.

Overweight and obesity in patients with established coronary heart disease: are we meeting the challenge?

De Bacquer D, De Backer G, Cokkinos D, Keil U, Montaye M, Ostör E, Pyörälä K, Sans S.

Eur Heart J. 2004 Jan;25(2):121-8.

PMID:
14720528
49.

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

Girman CJ, Rhodes T, Mercuri M, Pyörälä K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M; 4S Group and the AFCAPS/TexCAPS Research Group.

Am J Cardiol. 2004 Jan 15;93(2):136-41.

PMID:
14715336
50.

European guidelines on cardiovascular disease and prevention in clinical practice.

De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; Third Joint Force of European and other Societies on Cardiovascular Disease and Prevention in Clinical Practice.

Atherosclerosis. 2003 Nov;171(1):145-55. No abstract available. Corrected and republished in: Atherosclerosis. 2004 Apr;173(2):381-91.

PMID:
14686332

Supplemental Content

Loading ...
Support Center